We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+10.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$37.6B
AUM Growth
+$4.89B
(+15%)
Cap. Flow
+$2.25B
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
23.7%
Holding
2,051
New
98
Increased
1,226
Reduced
674
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$202M |
| 2 |
Linde
LIN
|
+$201M |
| 3 |
Apple
AAPL
|
+$192M |
| 4 |
NVIDIA
NVDA
|
+$187M |
| 5 |
Fastenal
FAST
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 2 |
IBM
IBM
|
+$38.3M |
| 3 |
Target
TGT
|
+$35M |
| 4 |
Sherwin-Williams
SHW
|
+$33.8M |
| 5 |
S&P Global
SPGI
|
+$32.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.52% |
| 2 | Industrials | 11.95% |
| 3 | Consumer Staples | 11.58% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Financials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Lexicon Pharmaceuticals
LXRX
$1.02B
| $81K | ﹤0.01% |
33,746
+2,764
| +9% | +$5.94K |
|
1852
Vivid Seats
SEAT
$77M
| $80.4K | ﹤0.01% |
+671
| New | +$78.7K |
|
1853
Planet Labs
PL
$7.3B
| $80.3K | ﹤0.01% |
31,493
+2,480
| +9% | +$5.6K |
|
1854
NextDecade
NEXT
$1.85B
| $79.7K | ﹤0.01% |
14,034
+1,106
| +9% | +$5.52K |
|
|
TERN
1855
DELISTED
Terns Pharmaceuticals
TERN
| $79.5K | ﹤0.01% |
12,121
+1,079
| +10% | +$7.05K |
|
1856
Atea Pharmaceuticals
AVIR
$379M
| $79.5K | ﹤0.01% |
19,671
+1,651
| +9% | +$6.46K |
|
1857
Community Health Systems
CYH
$385M
| $79.1K | ﹤0.01% |
22,590
+1,777
| +9% | +$6.01K |
|
1858
Health Catalyst
HCAT
$154M
| $77.2K | ﹤0.01% |
+10,259
| New | +$93.6K |
|
1859
Alignment Healthcare
ALHC
$4.02B
| $75.8K | ﹤0.01% |
15,291
+1,203
| +9% | +$7.7K |
|
1860
Rush Street Interactive
RSI
$3.24B
| $75.6K | ﹤0.01% |
11,616
+914
| +9% | +$4.92K |
|
|
CDMO
1861
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $75.5K | ﹤0.01% |
11,272
+999
| +10% | +$6.87K |
|
1862
Xeris Biopharma Holdings
XERS
$1.44B
| $74.2K | ﹤0.01% |
33,588
+2,739
| +9% | +$7.09K |
|
1863
TeraWulf
WULF
$9.15B
| $72.8K | ﹤0.01% |
27,666
+3,162
| +13% | +$6.24K |
|
1864
Oil States International
OIS
$522M
| $69.8K | ﹤0.01% |
11,335
-524
| -4% | -$3.13K |
|
|
TELL
1865
DELISTED
Tellurian Inc.
TELL
| $69.5K | ﹤0.01% |
105,071
+13,525
| +15% | +$9.17K |
|
|
VTYX
1866
DELISTED
Ventyx Biosciences
VTYX
| $69.1K | ﹤0.01% |
12,561
+1,042
| +9% | +$4.76K |
|
1867
Advantage Solutions
ADV
$484M
| $67.6K | ﹤0.01% |
624
+49
| +9% | +$4.82K |
|
1868
Applied Digital
APLD
$7.77B
| $67.1K | ﹤0.01% |
15,688
+2,112
| +16% | +$10.7K |
|
|
OSG
1869
DELISTED
Overseas Shipholding Group Inc.
OSG
| $67.1K | ﹤0.01% |
10,477
+250
| +2% | +$1.49K |
|
|
CTLP
1870
DELISTED
Cantaloupe
CTLP
| $66.3K | ﹤0.01% |
+10,304
| New | +$68K |
|
1871
NextNav
NN
$1.7B
| $66.2K | ﹤0.01% |
+10,065
| New | +$44.9K |
|
|
CNSL
1872
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $65.4K | ﹤0.01% |
15,141
+791
| +6% | +$3.44K |
|
1873
SkinHealth Systems
SKIN
$94.9M
| $64.6K | ﹤0.01% |
14,550
+1,006
| +7% | +$3.27K |
|
1874
Coherus Oncology
CHRS
$217M
| $63.7K | ﹤0.01% |
26,663
+3,028
| +13% | +$7.45K |
|
|
TDAY
1875
USA Today Co
TDAY
$1.23B
| $63.3K | ﹤0.01% |
25,924
+2,042
| +9% | +$4.59K |
|
Similar funds
ProShare Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, ProShare Advisors held 2,051 positions worth $37.6B, up 15% from $32.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $2.25B of net new capital in Q1 2024, opening 98 new positions and adding to 1,226 existing holdings. Its largest new stake was SS&C Technologies: 123,548 shares worth $7.95M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $163M trimmed.
- ProShare Advisors's largest Q1 2024 buy was SS&C Technologies: 123,548 shares worth $7.95M.
- ProShare Advisors added most to Microsoft in Q1 2024, an estimated $202M increase.
- ProShare Advisors's biggest Q1 2024 reduction was Walgreens Boots Alliance, cutting an estimated $163M.
- ProShare Advisors fully exited Splunk Inc in Q1 2024, selling an estimated $20.4M.
- ProShare Advisors's ten largest holdings make up 24% of its $37.6B portfolio in Q1 2024.
- ProShare Advisors opened 98 new positions and closed 47 in Q1 2024.
- ProShare Advisors's portfolio value rose 15% quarter-over-quarter to $37.6B.
Based on ProShare Advisors's 13F filing for Q1 2024, filed 8 May 2024.